SLC18A2 (solute carrier family 18 member A2)

2007-11-01  

Identity

HGNC
LOCATION
10q25.3
LOCUSID
ALIAS
PKDYS2,SVAT,SVMT,VAT2,VMAT2

Other Information

Locus ID:

NCBI: 6571
MIM: 193001
HGNC: 10935
Ensembl: ENSG00000165646

Variants:

dbSNP: 6571
ClinVar: 6571
TCGA: ENSG00000165646
COSMIC: SLC18A2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000165646ENST00000644641Q05940

Expression (GTEx)

0
1
2
3
4
5
6
7
8

Pathways

PathwaySourceExternal ID
Parkinson's diseaseKEGGhsa05012
Synaptic vesicle cycleKEGGko04721
Synaptic vesicle cycleKEGGhsa04721
Dopaminergic synapseKEGGko04728
Dopaminergic synapseKEGGhsa04728
Serotonergic synapseKEGGhsa04726
Cocaine addictionKEGGhsa05030
Cocaine addictionKEGGko05030
Amphetamine addictionKEGGhsa05031
Amphetamine addictionKEGGko05031
AlcoholismKEGGhsa05034
AlcoholismKEGGko05034
Neuronal SystemREACTOMER-HSA-112316
Transmission across Chemical SynapsesREACTOMER-HSA-112315
Neurotransmitter Release CycleREACTOMER-HSA-112310
Norepinephrine Neurotransmitter Release CycleREACTOMER-HSA-181430
Serotonin Neurotransmitter Release CycleREACTOMER-HSA-181429
Dopamine Neurotransmitter Release CycleREACTOMER-HSA-212676
Transmembrane transport of small moleculesREACTOMER-HSA-382551
SLC-mediated transmembrane transportREACTOMER-HSA-425407
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsREACTOMER-HSA-425366
Na+/Cl- dependent neurotransmitter transportersREACTOMER-HSA-442660

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA447215Psychotic DisordersDiseaseClinicalAnnotationassociatedPD27272046
PA447321Depressive Disorder, MajorDiseaseClinicalAnnotationassociatedPD22947179
PA448687bupropionChemicalClinicalAnnotationassociatedPD22947179
PA452233antipsychoticsChemicalClinicalAnnotationassociatedPD27272046

References

Pubmed IDYearTitleCitations
176526042007Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.151
198745742009Genetical genomic determinants of alcohol consumption in rats and humans.93
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.62
180457772008A network of dopaminergic gene variations implicated as risk factors for schizophrenia.54
210416082011Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.48
191561682009Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.46
112795282001Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes.42
172335322006Vesicular monoamine transporter 2: role as a novel target for drug development.40
182880902008Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.38
233634732013Brain dopamine-serotonin vesicular transport disease and its treatment.37

Citation

Dessen P

SLC18A2 (solute carrier family 18 member A2)

Atlas Genet Cytogenet Oncol Haematol. 2007-11-01

Online version: http://atlasgeneticsoncology.org/gene/49830/slc18a2